My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 299

    1.

    Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.

    Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO, Foulkes WD.

    BMC Cancer. 2007 Jul 24;7:134.PMID: 17650314 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prognostic markers in triple-negative breast cancer.

    Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO.

    Cancer. 2007 Jan 1;109(1):25-32.PMID: 17146782 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

    Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S.

    Anticancer Res. 2007 Jan-Feb;27(1B):547-55.PMID: 17348440 [PubMed - indexed for MEDLINE]Related articles

    4.

    Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

    Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J.

    Breast Cancer Res. 2007;9(1):R16.PMID: 17263897 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

    Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL.

    Cancer. 2009 Feb 15;115(4):899-908.PMID: 19130459 [PubMed - indexed for MEDLINE]Related articles

    6.

    Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer.

    Sasa M, Bando Y, Takahashi M, Hirose T, Nagao T.

    J Surg Oncol. 2008 Jan 1;97(1):30-4.PMID: 17929254 [PubMed - indexed for MEDLINE]Related articles

    7.

    Identification of a basal-like subtype of breast ductal carcinoma in situ.

    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

    Hum Pathol. 2007 Feb;38(2):197-204.PMID: 17234468 [PubMed - indexed for MEDLINE]Related articles

    8.

    Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

    Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO.

    Clin Cancer Res. 2008 Mar 1;14(5):1368-76.PMID: 18316557 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.

    Liu H, Fan Q, Zhang Z, Li X, Yu H, Meng F.

    Hum Pathol. 2008 Feb;39(2):167-74. Epub 2007 Nov 28.PMID: 18045647 [PubMed - indexed for MEDLINE]Related articles

    10.

    Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC.

    JAMA. 2006 Jun 7;295(21):2492-502.PMID: 16757721 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

    Am J Surg Pathol. 2008 Apr;32(4):544-52.PMID: 18300793 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

    Bryan BB, Schnitt SJ, Collins LC.

    Mod Pathol. 2006 May;19(5):617-21.PMID: 16528377 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

    Fadare O, Wang SA, Hileeto D.

    Hum Pathol. 2008 Mar;39(3):331-6.PMID: 18261623 [PubMed - indexed for MEDLINE]Related articles

    14.

    Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

    Dabbs DJ, Chivukula M, Carter G, Bhargava R.

    Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.PMID: 16941011 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

    Paredes J, Lopes N, Milanezi F, Schmitt FC.

    Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.PMID: 17123107 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Triple-negative breast cancer--towards a new entity]

    Miron L, Marinca A, Marinca M, Miron I.

    Rev Med Chir Soc Med Nat Iasi. 2008 Jan-Mar;112(1):51-8. Romanian. PMID: 18677903 [PubMed - indexed for MEDLINE]Related articles

    17.

    Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.

    Matkovic B, Juretic A, Separovic V, Novosel I, Separovic R, Gamulin M, Kruslin B.

    Tumori. 2008 Nov-Dec;94(6):838-44.PMID: 19267102 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression of basal and luminal cytokeratins in breast cancer and their correlation with clinicopathological prognostic variables.

    Mohammadizadeh F, Naimi A, Rajabi P, Ghasemibasir H, Eftekhari A.

    Indian J Med Sci. 2009 Apr;63(4):152-62.PMID: 19414985 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.

    Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens MR, Smeets A, Wildiers H, Vanden Bempt I.

    J Clin Pathol. 2009 Jul;62(7):624-8.PMID: 19561231 [PubMed - indexed for MEDLINE]Related articles

    20.

    Breast cancer subtypes and survival in patients with brain metastases.

    Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J.

    Breast Cancer Res. 2008;10(1):R20. Epub 2008 Feb 28.PMID: 18307763 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity